Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.
2.

A comparative study of protein expression in primary colorectal cancer and synchronous hepatic metastases: the significance of matrix metalloproteinase-1 expression as a predictor of liver metastasis.

Kim YW, Ko YT, Kim NK, Chung HC, Min BS, Lee KY, Park JP, Kim H.

Scand J Gastroenterol. 2010;45(2):217-25. doi: 10.3109/00365520903453158.

PMID:
20095886
3.

High levels of serum platelet-derived growth factor-AA and human epidermal growth factor receptor-2 are predictors of colorectal cancer liver metastasis.

Pan HD, Peng YF, Xiao G, Gu J.

World J Gastroenterol. 2017 Feb 21;23(7):1233-1240. doi: 10.3748/wjg.v23.i7.1233.

4.

Serum tissue inhibitor of metalloproteinase 1 (TIMP-1) and vascular endothelial growth factor A (VEGF-A) are associated with prognosis in esophageal cancer patients.

Kozłowski M, Laudański W, Mroczko B, Szmitkowski M, Milewski R, Łapuć G.

Adv Med Sci. 2013;58(2):227-34. doi: 10.2478/ams-2013-0017.

PMID:
23773968
5.

Clinicopathological features and prognosis in resectable synchronous and metachronous colorectal liver metastasis.

Tsai MS, Su YH, Ho MC, Liang JT, Chen TP, Lai HS, Lee PH.

Ann Surg Oncol. 2007 Feb;14(2):786-94. Epub 2006 Nov 14.

PMID:
17103254
6.

[Univariate and multivariate regression analyses of recurrence and metastasis of colon cancer after radical resection].

Ren JQ, Zhou ZW, Wan DS, Lu ZH, Chen G, Wang GQ, Tang SX, Wang JJ.

Ai Zheng. 2006 May;25(5):591-5. Chinese.

PMID:
16687080
7.

[Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma].

Moon JI, Kim JM, Jung GO, Chun JM, Choi GS, Park JB, Kwon CH, Kim SJ, Jo JW.

Korean J Hepatol. 2008 Jun;14(2):185-96. doi: 10.3350/kjhep.2008.14.2.185. Korean.

PMID:
18617766
8.

Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis.

Katayama A, Bandoh N, Kishibe K, Takahara M, Ogino T, Nonaka S, Harabuchi Y.

Clin Cancer Res. 2004 Jan 15;10(2):634-40.

9.

Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.

Pfannschmidt J, Bade S, Hoheisel J, Muley T, Dienemann H, Herpel E.

Thorac Cardiovasc Surg. 2009 Oct;57(7):403-8. doi: 10.1055/s-0029-1185820. Epub 2009 Sep 30.

PMID:
19795327
10.

High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas.

Niedergethmann M, Hildenbrand R, Wostbrock B, Hartel M, Sturm JW, Richter A, Post S.

Pancreas. 2002 Aug;25(2):122-9.

PMID:
12142733
11.

Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.

Gouyer V, Conti M, Devos P, Zerimech F, Copin MC, Créme E, Wurtz A, Porte H, Huet G.

Cancer. 2005 Apr 15;103(8):1676-84.

12.

Resection of synchronous liver metastases from colorectal cancer.

Fujita S, Akasu T, Moriya Y.

Jpn J Clin Oncol. 2000 Jan;30(1):7-11.

PMID:
10770561
13.

Usefulness of VEGF, MMP-2, MMP-3 and TIMP-2 serum level evaluation in patients with adrenal tumours.

Kolomecki K, Stepien H, Bartos M, Kuzdak K.

Endocr Regul. 2001 Mar;35(1):9-16.

PMID:
11308991
14.

Prediction of Early Recurrence After Curative Resection of Colorectal Liver Metastasis and Subsequent S-1 Chemotherapy.

Yamauchi K, Kokuryo T, Yokoyama Y, Uehara K, Yamaguchi J, Nagino M.

Anticancer Res. 2016 May;36(5):2175-9.

PMID:
27127120
15.

Prevalence of vascular-endothelial growth factor, matrix metalloproteinases and tissue inhibitors of metalloproteinases in primary breast cancer.

Jobim FC, Xavier NL, Uchoa DM, Cruz DB, Saciloto M, Chemello N, Schwartsmann G.

Braz J Med Biol Res. 2009 Oct;42(10):979-87. Epub 2009 Sep 4.

16.

The expression of MMP-2 and TIMP-2 in patients with primary colorectal adenocarcinoma: correlation with liver metastasis.

Mukai M, Sadahiro S, Tokunaga N, Ishizu K, Ito I, Kameya T, Ishikawa K, Iwase H, Suzuki T, Ishida H, Tajima T, Makuuchi H.

Oncol Rep. 1999 Sep-Oct;6(5):969-73.

PMID:
10425288
17.

Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma.

Manenti L, Paganoni P, Floriani I, Landoni F, Torri V, Buda A, Taraboletti G, Labianca R, Belotti D, Giavazzi R.

Eur J Cancer. 2003 Sep;39(13):1948-56.

PMID:
12932675
18.

Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer.

Kwon KA, Kim SH, Oh SY, Lee S, Han JY, Kim KH, Goh RY, Choi HJ, Park KJ, Roh MS, Kim HJ, Kwon HC, Lee JH.

BMC Cancer. 2010 May 14;10:203. doi: 10.1186/1471-2407-10-203.

19.

TIMP-1 and VEGF-165 serum concentration during first-line therapy of ovarian cancer patients.

Mahner S, Woelber L, Eulenburg C, Schwarz J, Carney W, Jaenicke F, Milde-Langosch K, Mueller V.

BMC Cancer. 2010 Apr 13;10:139. doi: 10.1186/1471-2407-10-139.

20.

[Therapeutic strategy for hepatic metastasis of primary colon cancer].

Yukawa N, Akaike M, Sugimasa Y, Takemiya S, Motohashi H.

Gan To Kagaku Ryoho. 2001 Oct;28(11):1565-8. Japanese.

PMID:
11707981

Supplemental Content

Support Center